Page last updated: 2024-10-24

chlorambucil and Malabsorption Syndromes

chlorambucil has been researched along with Malabsorption Syndromes in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Malabsorption Syndromes: General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rambaud, JC1
Matuchansky, C1
Bognel, JC1
Bognel, C1
Bernier, JJ1
Scotto, J1
Perol, C1
Ferrier, JP1
Mihaesco, E1
Hurez, D1
Seligmann, M1

Other Studies

1 other study available for chlorambucil and Malabsorption Syndromes

ArticleYear
[A further case of alpha chain disease in a Eurasian].
    Annales de medecine interne, 1970, Volume: 121, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Blood Protein Disorders; Chlorambucil; Humans; Immunity

1970